Publications by authors named "Siminder Atwal"

Claim this Profile
Z
Zanubrutinib for the treatment of relapsed or refractory mantle cell lymphoma.
Constantine S Tam, Stephen Opat, David Simpson, Gavin Cull, Javier Munoz, Siminder Kaur Atwal

Blood Adv· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Zanubrutinib for the treatment of patients with Waldenström macroglobulinemia: 3 years of follow-up.
Judith Trotman, Stephen Opat, David Gottlieb, David Simpson, Paula Marlton, Siminder Kaur Atwal

Blood· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A head-to-head Phase III study comparing zanubrutinib versus ibrutinib in patients with Waldenström macroglobulinemia.
Constantine S Tam, Veronique LeBlond, William Novotny, Roger G Owen, Alessandra Tedeschi, Siminder Atwal

Future Oncol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of circulating tumor cells and circulating tumor DNA in non-small cell lung cancer: association with clinical endpoints in a phase II clinical trial of pertuzumab and erlotinib.
Elizabeth A Punnoose, Siminder Atwal, Weiqun Liu, Rajiv Raja, Bernard M Fine

Clin Cancer Res· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular biomarker analyses using circulating tumor cells.
Elizabeth A Punnoose, Siminder K Atwal, Jill M Spoerke, Heidi Savage, Ajay Pandita

PLoS One· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis